Literature DB >> 8526376

Estrogen metabolite ratios and risk assessment of hormone-related cancers. Assay validation and prediction of cervical cancer risk.

D W Sepkovic1, H L Bradlow, G Ho, S E Hankinson, L Gong, M P Osborne, J Fishman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8526376     DOI： 10.1111/j.1749-6632.1995.tb12149.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

1.  Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.

Authors:  Ting-Yan Shi; Mei-Ling Zhu; Jing He; Meng-Yun Wang; Qiao-Xin Li; Xiao-Yan Zhou; Meng-Hong Sun; Zhi-Ming Shao; Ke-Da Yu; Xi Cheng; Xiaohua Wu; Qingyi Wei
Journal:  Hum Genet       Date:  2012-11-20       Impact factor: 4.132

2.  Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention.

Authors:  Levon Ashrafian; Gennady Sukhikh; Vsevolod Kiselev; Mikhail Paltsev; Vadim Drukh; Igor Kuznetsov; Ekaterina Muyzhnek; Inna Apolikhina; Evgeniya Andrianova
Journal:  EPMA J       Date:  2015-12-21       Impact factor: 6.543

3.  Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate.

Authors:  Ghadire Mirabolghasemi; Zahra Kamyab
Journal:  Int J Fertil Steril       Date:  2016-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.